Mamoru Yamamoto
Toyama, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Multiancestry genome-wide association and multiomics analyses elucidate spatiocellular features of multiple sclerosis genetics.
Journal: Nature genetics
Published: May 07, 2025
Effectiveness of satralizumab in a real-world clinical setting in Japan: Interleukin-6 receptor inhibition in neuromyelitis optica spectrum disorder: A six-month interim analysis of a multicenter medical chart review.
Journal: Multiple sclerosis and related disorders
Published: July 31, 2024
Contribution of germline and somatic mutations to risk of neuromyelitis optica spectrum disorder.
Journal: Cell genomics
Published: May 20, 2024
Increased Cerebrospinal Fluid Adenosine 5'-Triphosphate Levels in Patients with Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy.
Journal: Neurology research international
Published: October 17, 2023
Identification of double-stranded DNA in the cerebrospinal fluid of patients with acute neuromyelitis optica spectrum disorder.
Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: May 23, 2022
Elderly patients with suspected Charcot-Marie-Tooth disease should be tested for the TTR gene for effective treatments.
Journal: Journal of human genetics
Published: October 19, 2021
A Parkinson's disease patient displaying increased neuromelanin-sensitive areas in the substantia nigra after rehabilitation with tDCS: a case report.
Journal: Neurocase
Published: September 10, 2021
Clinicopathologic Features of Oculopharyngodistal Myopathy With LRP12 CGG Repeat Expansions Compared With Other Oculopharyngodistal Myopathy Subtypes.
Journal: JAMA neurology
Published: May 28, 2021
Serum neurofilament light chain in chronic inflammatory demyelinating polyneuropathy.
Journal: Brain and behavior
Published: November 02, 2020
The Spinal Cord Uptake of Fluorodeoxyglucose in a Patient with Relapsing Polychondritis.
Journal: Internal medicine (Tokyo, Japan)
Published: February 14, 2020
Cerebrospinal fluid ATP as a potential biomarker in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes (MELAS).
Journal: Mitochondrion
Published: August 15, 2019
Last Updated: 09/26/2026